"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Potassium Acetate Injection, USP is indicated as a source of potassium, for addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.
DOSAGE AND ADMINISTRATION
Potassium Acetate Injection, USP is administered intravenously only after dilution in a larger volume of fluid. The dose and rate of administration are dependent upon the individual needs of the patient. ECG and serum potassium should be monitored as a guide to dosage. Using aseptic technique, all or part of the contents of one or more vials may be added to other intravenous fluids to provide any desired number of milliequivalents (mEq) of potassium (K+) with an equal number of milli- equivalents of acetate (CH3COO–).
Parenteral drug products should be inspected visually for particulate matter and discolouration prior to administration, whenever solution and container permit. See PRECAUTIONS.
AVAILABILITY OF DOSAGE FORMS
|Product Number||Potassium Acetate Content(%)||K+ mmol/mL or mEq/mL||CH3COO– mmol/mL or mEq/mL||mOsmol/mL||Fill Volume mL|
Flip-top vials in boxes of 25.
Store between 15 and 30°C.Do not permit to freeze.
PHARMACEUTICAL PARTNERS OF CANADA, A Division of Abraxis BioScience, Inc. Richmond Hill, ON L4B 3P6. 1-877-821-7724. Rev 31 Jan 07. FDA Rev date: 12/24/2002
Last reviewed on RxList: 11/10/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Potassium Acetate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.